Juan Espinosa Pereiro Juan Espinosa Pereiro, graduated in Medicine from the University of Santiago de Compostela. Specialist in Internal Medicine and Infectious Diseases at the H. U. Vall d'Hebrón, in Barcelona. He is a researcher and clinical member of the International Health Program of the Catalan Institute of Health. Collaborating researcher in the EUSAT-RCS and EU-PEARL projects. He also participates in several competitive projects within the national scope. Member of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), and within them their respective mycobacteria study groups (GEIM and ESGMYC, respectively). He has participated in the publication of several scientific articles in the field of Infectious Diseases, including tuberculosis, Chagas disease and COVID-19. Institutions of which they are part Predoctoral researcher Infectious Diseases Vall Hebron Institut de Recerca Accident and Emergency Department General Hospital Doctor Infectious Diseases Cross-departmental services Twitter Orcid Email Juan Espinosa Pereiro Twitter Orcid Email Institutions of which they are part Predoctoral researcher Infectious Diseases Vall Hebron Institut de Recerca Accident and Emergency Department General Hospital Doctor Infectious Diseases Cross-departmental services Juan Espinosa Pereiro, graduated in Medicine from the University of Santiago de Compostela. Specialist in Internal Medicine and Infectious Diseases at the H. U. Vall d'Hebrón, in Barcelona. He is a researcher and clinical member of the International Health Program of the Catalan Institute of Health. Collaborating researcher in the EUSAT-RCS and EU-PEARL projects. He also participates in several competitive projects within the national scope. Member of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) and the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), and within them their respective mycobacteria study groups (GEIM and ESGMYC, respectively). He has participated in the publication of several scientific articles in the field of Infectious Diseases, including tuberculosis, Chagas disease and COVID-19.
EDUCATION 2007-2013: Degree with Extraordinary Award in Medicine. Universidade de Santiago de Compostela. PhD candidate: “Mycobacterium tuberculosis resistance to and optimization of first line drugs.” October 2019 to present: Universitat Autónoma de Barcelona, Barcelona, Cataluña, Spain. Director: Adrián Sánchez-Montalvá. Residence May 2014 -May 2019: Internal Medicine. Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Cataluña, Spain. Subspecialization May 2017 to May 2019: Infectious Diseases. Hospital Universitari Vall d’Hebron, Universitat Autònoma de Barcelona, Barcelona, Cataluña, Spain. Internships November-December 2018: Tropical Diseases Oxford University Clinical Research Unit Vietnam, Hospital for Tropical Diseases, Ho Chi Minh City, Vietnam. October-December 2019 and June-July 2022: Tuberculosis Instituto de Enfermedades Respiratorias y del Ambiente (INERAM), Asunción, Paraguay. Programa Nacional de Control de la Tuberculosis (PNCT), Asunción Paraguay. PROFESSIONAL EXPERIENCE Licensed Physician number 50420, in Barcelona, 2014. May 2019 to present: Emergency Department, attending physician. May 2019 to present: Global Health and Tropical Diseases. RESEARCH EXPERIENCE Competitive grants participation: November 2019 to present: Pre-doctoral Research Fellow at EU Patient-cEntric clinical tRial pLatform (EU-PEARL). Grant number 853966. May 2019 to present: Pre-doctoral Research Fellow at European-Latin American TB Research Collaboration Network (EUSAT-RCS). Grant number: 823890. Good clinical practice certificate: until April 23rd 2023. PUBLICATIONS First-author: A restrospective study on the influence of sibling’s relatedness in Bolivian patients with chronic Chagas disease. Parasites and Vectors. 2019 12:260 MDR Tuberculosis Treatment. Medicina (Kaunas). 2022 Jan 26;58(2):188. doi: 10.3390/medicina58020188. Co-authored: Ulcers on psoriatic plaques in a patient with advanced Human Immunodeficiency Virus infection. Enfermedades Infecciosas y Microbiología clínica, 2017 Nov;35(9):605-606. PMID 27240445. Mixed connective tissue disease and epitope spreading: An Historical Cohort Study. Journal of Clinical Rheumatology. 2017 Apr;23(3): 155-159. PMID 28248800. Usefulness of FDG PET/CT in the management of tuberculosis. PLoS ONE. 2019 14 (8): e0221516 Tigecycline-associated hypofibrinogenemia in a real-world setting. International Journal of Clinical Pharmacology. 2020 Aug;42(4):1184-1189. PMID: 32504166. Blastocystis sp. carriage and irritable bowel syndrome: is the association already established? Biology. 2021, 10, 340. Risk of SARS-COV-2 infection in previously infected and non-infected cohorts of health workers at high risk of exposure. Journal of Clinical Medicine. 2021 April, 10, 1968. Early outcomes in adults hospitalized with severe SARS-CoV-2 infection receiving tocilizumab. Medicina Clinica. 2021 Jun 18:S0025-7753(21)00360-2. PMID: 34544604. Impact of the COVID-19 pandemic on tuberculosis management in Spain. International Journal of Infectious Diseases. 2021 Jul;108:300-305. PMID: 33930543. Imported cystic echinococcosis in Spain: a systematic review. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2021 Oct 1;115(10):1184-1189. PMID: 33631003. Other publications Guía práctica de actuación en epidemias de COVID-19 en residencias para personas mayores. [Practical actuation guideline for COVID-19 epidemics in nursing facilities]. Sociedad Española de Medicina de Familia y Comunitaria. Enero 2021.
Projects Estrategias de optimización del tratamiento de la tuberculosis pulmonar IP: Israel Molina Romero Collaborators: Juan Espinosa Pereiro, Laia Perez Lasarte Funding agency: Instituto de Salud Carlos III Funding: 65000 Reference: CM22/00246 Duration: 31/03/2023 - 30/03/2025 Malalties infeccioses IP: Vicenç Falcó Ferrer Collaborators: Jose Santos Santiago, Maria Luisa Aznar Ruiz de Alegria, Adria Curran Fàbregas, Jorge Nestor Garcia Perez, Oscar Len Abad, Mª Carmen Ferrer Barberà, Javier Gomis Rodriguez, Diana Pou Ciruelo, Begoña Treviño Maruri, Nuria Fernández Hidalgo, Joan Gavaldà Santapau, Juan Espinosa Pereiro, Bibiana Planas Ribas, Ma Dolores Rodríguez Pardo, Pau Bosch Nicolau, David Perea Pérez, Israel Molina Romero, Patricia Álvarez López, Vicente Descalzo Jorro, Marta Sanchiz Cruz, Nuria Serre Delcor, Julia Sellares Nadal, Fernando M Salvador Velez, Isabel Ruiz Camps, Jordi Gómez i Prat, María José Buzón Gómez, Hakima Ouaarab Essadek, Paula Suanzes Diez, Jordi Navarro Mercadé, Esperanza Esteban Serna, Raisa Morales Martinez, Joaquin Burgos Cibrian, Nerea Sanchez Gaona, Joan Rey Cano, Adrián Sánchez Montalvá, Cristina Mancebo Perez, Montserrat Llinás Vidal, Malalties infeccioses, Maider Arando Lasagabaster, Ibai Los Arcos Bertiz, Claudia Broto Cortes, Meritxell Genesca Ferrer, Ines Mercedes Oliveira Souto, Silvina Andrea Magnani, Yasmine Margaret Baktash Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 60000 Reference: 2021 SGR 00764 Duration: 01/01/2022 - 30/06/2025 EU Patient- cEntric clinicAl tRial pLatform - EU PEARL. IP: Joan Genescà Ferrer Collaborators: Santiago Pérez Hoyos, Anna Sanjuan Viaplana, Xavier Cañas Perea, Juan Espinosa Pereiro, Juan Manuel Pericàs Pulido, José Antonio Ramos Quiroga, Israel Molina Romero, Alex Sánchez Pla, Inmaculada Fuentes Camps, Adrián Sánchez Montalvá, Pol Ibañez Jimenez, Olga Sánchez- Maroto Carrizo, Gara Arteaga Henriquez, EU Patient- cEntric clinicAl tRial pLatform - EU PEARL., Janna Anthonina Slabbekoorn, Albert Barberà LLuis Funding agency: The Innovative Medicines Initiative Funding: 1987375 Reference: EU-PEARL_H2020_IMI2-2018 Duration: 01/11/2019 - 30/04/2023 European-Latin American TB Research Collaboration Network IP: Adrián Sánchez Montalvá Collaborators: Maria Luisa Aznar Ruiz de Alegria, Juan Espinosa Pereiro Funding agency: EUROPEAN COMMISSION Funding: 312800 Reference: EUSAT-RCS_H2020MSCA-RISE2018 Duration: 01/04/2019 - 31/03/2024 Pagination Current page 1 Page 2 Next page › Last page »
